Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $258.47 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $76.37 | 5 | $0 (2024) |
| Alkermes, Inc. | $41.91 | 3 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $30.49 | 2 | $0 (2021) |
| ABBVIE INC. | $27.86 | 2 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $26.10 | 1 | $0 (2024) |
| Tris Pharma Inc | $17.45 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $13.99 | 1 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $12.78 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.52 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $101.79 | 6 | Teva Pharmaceuticals USA, Inc. ($44.25) |
| 2023 | $30.56 | 2 | Teva Pharmaceuticals USA, Inc. ($17.24) |
| 2022 | $27.14 | 2 | Alkermes, Inc. ($14.36) |
| 2021 | $98.98 | 7 | Neurocrine Biosciences, Inc. ($30.49) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Central Nervous System | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Neurology | ||||||
| 02/22/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ADHD | ||||||
| 12/05/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Central Nervous System | ||||||
| 03/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 01/28/2022 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CNS | ||||||
| 11/17/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: CNS | ||||||
| 09/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: CNS | ||||||
| 05/14/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Central Nervous System | ||||||
| 03/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROLOGY | ||||||
| 03/04/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 64 | 248 | $54,690 | $13,107 |
| 2022 | 3 | 121 | 483 | $101,050 | $28,017 |
| 2021 | 3 | 52 | 104 | $19,795 | $5,688 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 182 | $43,680 | $10,808 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 36 | $5,760 | $1,252 | 21.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 15 | 30 | $5,250 | $1,047 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 269 | $64,560 | $19,082 | 29.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 40 | 150 | $26,250 | $5,949 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 64 | $10,240 | $2,986 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 31 | $7,440 | $2,356 | 31.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 18 | 45 | $7,875 | $2,002 | 25.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 28 | $4,480 | $1,330 | 29.7% |
About Larry Elj, RN
Larry Elj, RN is a Psychiatric Unit healthcare provider based in Grand Rapids, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1376150235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Larry Elj, RN has received a total of $258.47 in payments from pharmaceutical and medical device companies, with $101.79 received in 2024. These payments were reported across 17 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($258.47).
As a Medicare-enrolled provider, Elj has provided services to 237 Medicare beneficiaries, totaling 835 services with total Medicare billing of $46,812. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatric Unit
- Other Specialties Psychiatric/Mental Health
- Location Grand Rapids, MN
- Active Since 09/25/2020
- Last Updated 11/23/2020
- Taxonomy Code 273R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376150235
Products in Payments
- UZEDY (Drug) $31.15
- INGREZZA (Drug) $30.49
- Austedo XR (Drug) $30.34
- VRAYLAR (Drug) $27.86
- VIVITROL (Drug) $27.55
- FANAPT (Drug) $26.10
- Dyanavel XR (Drug) $17.45
- AUSTEDO (Drug) $14.88
- Vivitrol (Drug) $14.36
- Qelbree (Drug) $13.99
- JORNAY PM (Drug) $12.78
- TRINTELLIX (Drug) $11.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.